Skip to content

Generate Biomedicines, Inc.

GENB · XNAS

CIK 2100782fmd_1M8ZN5R6DGW821M2A27JMM9852Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods

Loading statement
Generate Biomedicines, Inc. (GENB) financial statements · FinancialMD